The prevalence of non-alcoholic fatty liver disease (NAFLD) is continually increasing due to
the global obesity epidemic. NAFLD comprises a systemic metabolic disease accompanied …

Antisense oligonucleotides (ASOs) are short single stranded synthetic RNA or DNA
molecules, whereas double-stranded RNA nucleotide sequences are called small …

Background: NAFLD has become the leading cause of chronic liver disease worldwide
afflicting about one quarter of the adult population. NASH is a severe subtype of NAFLD …

Nonalcoholic fatty liver disease (NAFLD) is emerging as a leading cause of chronic liver
disease worldwide. Despite intensive nonclinical and clinical research in this field, no …

Hepatic steatosis, the buildup of neutral lipids in lipid droplets (LDs), is commonly referred to
as metabolic dysfunction-associated steatotic liver disease (MASLD) when alcohol or viral …

Hepatocellular carcinoma (HCC) is one of the most fatal and fastest growing malignancies.
Recently, nonalcoholic steatohepatitis (NASH), characterized by liver steatosis …

The primary hepatic consequence of obesity is non-alcoholic fatty liver disease (NAFLD),
affecting about 25% of the global adult population. Non-alcoholic steatohepatitis (NASH) is a …

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are
emerging as leading causes of liver disease worldwide and have been recognized as one of …

Diabetic kidney disease (DKD) is the most common cause of severe renal disease
worldwide and the single strongest predictor of mortality in diabetes patients. Kidney …

Adipose tissue macrophages (ATMs) regulate the occurrence of obesity and its related
diseases. Here, we found that serine/threonine protein kinase 24 (Stk24) expression is …